161 related articles for article (PubMed ID: 35731989)
1. Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
Armenian SH; Chen Y; Hageman L; Wu J; Landier W; Bosworth A; Francisco L; Schlichting E; Bhatia R; Salzman D; Wong FL; Weisdorf DJ; Forman SJ; Arora M; Bhatia S
J Clin Oncol; 2022 Oct; 40(28):3278-3288. PubMed ID: 35731989
[TBL] [Abstract][Full Text] [Related]
2. Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood.
Holmqvist AS; Chen Y; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas NA; Bosworth A; Te HS; Goldman FD; Rosenthal J; Wong FL; Weisdorf DJ; Armenian SH; Bhatia S
Cancer; 2023 Feb; 129(4):624-633. PubMed ID: 36484292
[TBL] [Abstract][Full Text] [Related]
3. Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study.
Arora M; Chen Y; Hageman L; Wu J; Landier W; Francisco L; Kung M; Ness E; Bosworth A; Pamukcuoglu M; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
Cancer; 2020 Jul; 126(14):3322-3329. PubMed ID: 32413187
[TBL] [Abstract][Full Text] [Related]
4. Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study Report.
Wadhwa A; Chen Y; Hageman L; Schlichting E; Funk E; Hicks J; Balas N; Siler A; Wu J; Francisco L; Holmqvist A; Gupta A; Lund T; Orchard PJ; Armenian S; Arora M; Bhatia S
Transplant Cell Ther; 2022 Mar; 28(3):157.e1-157.e9. PubMed ID: 34879288
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Cancer; 2019 Dec; 125(24):4498-4508. PubMed ID: 31469420
[TBL] [Abstract][Full Text] [Related]
6. Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Battles K; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2261-2266. PubMed ID: 31278995
[TBL] [Abstract][Full Text] [Related]
7. Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.
Bhatia S; Dai C; Landier W; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Bosworth A; Te HS; Francisco L; Bhatia R; Salzman D; Goldman FD; Forman SJ; Weisdorf DJ; Wong FL; Arora M; Armenian SH
JAMA Oncol; 2021 Nov; 7(11):1626-1634. PubMed ID: 34499078
[TBL] [Abstract][Full Text] [Related]
8. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Blood Adv; 2021 Oct; 5(20):4102-4111. PubMed ID: 34461633
[TBL] [Abstract][Full Text] [Related]
9. Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.
Wu J; Chen Y; Hageman L; Francisco L; Ness EC; Parman M; Kung M; Watson JA; Weisdorf DJ; Snyder DS; McGlave PB; Forman SJ; Arora M; Armenian SH; Bhatia R; Bhatia S
Cancer; 2019 Nov; 125(22):4033-4042. PubMed ID: 31412155
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
Stefanski KJ; Anixt JS; Goodman P; Bowers K; Leisenring W; Scott Baker K; Burns K; Howell R; Davies S; Robison LL; Armstrong GT; Krull KR; Recklitis C
J Natl Cancer Inst; 2021 Apr; 113(4):481-495. PubMed ID: 32797189
[TBL] [Abstract][Full Text] [Related]
11. Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS report.
Holmqvist AS; Meng Q; Dai C; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas N; Bosworth A; Te HS; Bhatia R; Rosenthal J; Wong FL; Weisdorf D; Armenian SH; Bhatia S
Leukemia; 2024 Mar; 38(3):601-609. PubMed ID: 38374408
[TBL] [Abstract][Full Text] [Related]
12. PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor.
Shinzato A; Tabuchi K; Atsuta Y; Inoue M; Inagaki J; Yabe H; Koh K; Kato K; Ohta H; Kigasawa H; Kitoh T; Ogawa A; Takahashi Y; Sasahara Y; Kato S; Adachi S
Pediatr Blood Cancer; 2013 Sep; 60(9):1513-9. PubMed ID: 23512888
[TBL] [Abstract][Full Text] [Related]
13. Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.
Arora M; Sun CL; Ness KK; Teh JB; Wu J; Francisco L; Armenian SH; Schad A; Namdar G; Bosworth A; Kuo L; Weisdorf DJ; Forman SJ; Bhatia S
JAMA Oncol; 2016 Oct; 2(10):1277-1286. PubMed ID: 27254472
[TBL] [Abstract][Full Text] [Related]
14. Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study report.
Oliver MM; Meng Q; Hageman L; Landier W; Balas N; Ross E; Francisco L; Bosworth A; Te HS; Wong FL; Bhatia R; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Cancer; 2024 Mar; 130(5):803-815. PubMed ID: 37880912
[TBL] [Abstract][Full Text] [Related]
15. Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation.
Miyao K; Kuwatsuka Y; Murata M; Nagafuji K; Teshima T; Takeuchi Y; Shiratori S; Najima Y; Uchida N; Tanaka M; Sawa M; Ota S; Fukuda T; Ozawa Y; Kako S; Kawakita T; Ara T; Tanaka J; Kanda Y; Atsuta Y; Kanda J; Terakura S;
Transplant Cell Ther; 2022 Mar; 28(3):153.e1-153.e11. PubMed ID: 34954151
[TBL] [Abstract][Full Text] [Related]
16. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.
Sun CL; Kersey JH; Francisco L; Armenian SH; Baker KS; Weisdorf DJ; Forman SJ; Bhatia S
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1073-80. PubMed ID: 23583827
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
Woolfrey AE; Gooley TA; Sievers EL; Milner LA; Andrews RG; Walters M; Hoffmeister P; Hansen JA; Anasetti C; Bryant E; Appelbaum FR; Sanders JE
Blood; 1998 Nov; 92(10):3546-56. PubMed ID: 9808546
[TBL] [Abstract][Full Text] [Related]
18. Potentially inappropriate medications in geriatric blood or marrow transplantation (BMT) survivors: A BMT Survivor Study report.
Sanchez-Luege S; Landier W; Dai C; Hageman L; Ross ES; Balas NA; Bosworth A; Te HS; Wu J; Francisco L; Wong FL; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Cancer; 2023 Feb; 129(3):473-482. PubMed ID: 36413424
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
